Alam Kamran bought TSHA
January 12, 2026 · Form 4 insider transaction
Alam Kamran bought 359,000 shares of Taysha Gene Therapies, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
359,000
Price
$0.00
Total value
N/A
InsiderAlam Kamran
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 12, 2026
Filing dateJanuary 14, 2026
Shares owned after1,546,603
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a restricted stock unit ("RSU") award. The RSUs will vest in four equal annual installments beginning on January 12, 2027, subject to the Reporting Person's continuous service through each applicable vesting date.